Ashton Thomas Private Wealth, LLC Dexcom Inc Transaction History

Ashton Thomas Private Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$110.31 - $140.45 $15,443 - $19,663	-140 Reduced 8.15%	1,578 $179 Million
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $25,128 - $30,822	-220 Reduced 11.35%	1,718 $238 Million
Q4 2023 Apr 19, 2024	BUY	$75.49 - $124.16 $146,299 - $240,622	1,938 New	1,938 $240 Million
Q2 2023 Apr 22, 2024	BUY	$112.47 - $130.98 $24,630 - $28,684	219 Added 12.75%	1,937 $249 Million
Q2 2022 Apr 19, 2024	SELL	$67.99 - $132.89 $39,774 - $77,740	-585 Closed	0 $0
Q1 2022 Apr 19, 2024	BUY	$94.08 - $130.2 $55,036 - $76,167	585 New	585 $299 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.